Journal of Cardiac Failure
@jcardfail.bsky.social
The official journal of @hfsa.bsky.social for original peer-reviewed research & reviews.
Co-EIC:
@robmentz.bsky.social &
@dranulala.bsky.social
https://linktr.ee/jcardfail
Co-EIC:
@robmentz.bsky.social &
@dranulala.bsky.social
https://linktr.ee/jcardfail
New scientific statement from @hfsa.bsky.social & AAHFN! Integrated health technologies are reshaping HF care💻, from telemonitoring to mobile apps to implantables. Benefits include ⬆️QoL & ⬇️hospitalizations, but success depends on many complex factors.
🔗 bit.ly/3Z5bgzb
🔗 bit.ly/3Z5bgzb
January 27, 2026 at 7:51 PM
New scientific statement from @hfsa.bsky.social & AAHFN! Integrated health technologies are reshaping HF care💻, from telemonitoring to mobile apps to implantables. Benefits include ⬆️QoL & ⬇️hospitalizations, but success depends on many complex factors.
🔗 bit.ly/3Z5bgzb
🔗 bit.ly/3Z5bgzb
Today’s AHF pts are older, obese & multimorbid w/“inflammaging” rather than just pump failure. The latest SotA Review suggests early initiation of 4 GDMT pillars during AHF—and possibly added anti-inflammatory therapy—may improve longer-term outcomes & remission.
🔗 https://bit.ly/3Z2S5Wx
🔗 https://bit.ly/3Z2S5Wx
January 22, 2026 at 7:27 PM
Today’s AHF pts are older, obese & multimorbid w/“inflammaging” rather than just pump failure. The latest SotA Review suggests early initiation of 4 GDMT pillars during AHF—and possibly added anti-inflammatory therapy—may improve longer-term outcomes & remission.
🔗 https://bit.ly/3Z2S5Wx
🔗 https://bit.ly/3Z2S5Wx
A New Year brings new insights.
The January issue of JCF is here, highlighting timely research and emerging conversations shaping the year ahead in heart failure science.
Start reading 📖 https://onlinejcf.com/current
#HeartFailure #Cardiology
The January issue of JCF is here, highlighting timely research and emerging conversations shaping the year ahead in heart failure science.
Start reading 📖 https://onlinejcf.com/current
#HeartFailure #Cardiology
January 15, 2026 at 6:37 PM
A New Year brings new insights.
The January issue of JCF is here, highlighting timely research and emerging conversations shaping the year ahead in heart failure science.
Start reading 📖 https://onlinejcf.com/current
#HeartFailure #Cardiology
The January issue of JCF is here, highlighting timely research and emerging conversations shaping the year ahead in heart failure science.
Start reading 📖 https://onlinejcf.com/current
#HeartFailure #Cardiology
New science 🚨! In the BRING-UP-3 HF study, among ambulatory HF pts in Italy, 65% of HFrEF pt received all 4 GDMT pillars. BBs & RASi/ARNI >90%, MRAs & SGLT2i >80% (though target doses still low). SGLT2i already common in HFmrEF (72%) & HFpEF (50%)!
🔗 https://bit.ly/44jVymK
🔗 https://bit.ly/44jVymK
January 15, 2026 at 4:48 PM
New science 🚨! In the BRING-UP-3 HF study, among ambulatory HF pts in Italy, 65% of HFrEF pt received all 4 GDMT pillars. BBs & RASi/ARNI >90%, MRAs & SGLT2i >80% (though target doses still low). SGLT2i already common in HFmrEF (72%) & HFpEF (50%)!
🔗 https://bit.ly/44jVymK
🔗 https://bit.ly/44jVymK
Despite strong evidence, GDMT remains underused. In this Indian expert consensus doc, using a modified Delphi process, authors propose simplified, patient-profile–based guidance to enable early, safe initiation of the 4 GDMT pillars & improve outcomes in HFrEF.
🔗 bit.ly/4iZB48Q
🔗 bit.ly/4iZB48Q
January 14, 2026 at 7:15 PM
Despite strong evidence, GDMT remains underused. In this Indian expert consensus doc, using a modified Delphi process, authors propose simplified, patient-profile–based guidance to enable early, safe initiation of the 4 GDMT pillars & improve outcomes in HFrEF.
🔗 bit.ly/4iZB48Q
🔗 bit.ly/4iZB48Q
Tricuspid regurgitation in ❤️🩹 HFpEF isn’t benign💡
In 206 pts undergoing invasive exercise testing 🚴♀️, moderate–severe TR (vs absent-mild) was linked to ...
⬇️ cardiac reserve — lower peak CO, higher mPAP–CO slope
3.3× higher 5-yr composite HFH or death.
🔗 https://bit.ly/4hZ3YWl
In 206 pts undergoing invasive exercise testing 🚴♀️, moderate–severe TR (vs absent-mild) was linked to ...
⬇️ cardiac reserve — lower peak CO, higher mPAP–CO slope
3.3× higher 5-yr composite HFH or death.
🔗 https://bit.ly/4hZ3YWl
December 18, 2025 at 4:17 PM
Tricuspid regurgitation in ❤️🩹 HFpEF isn’t benign💡
In 206 pts undergoing invasive exercise testing 🚴♀️, moderate–severe TR (vs absent-mild) was linked to ...
⬇️ cardiac reserve — lower peak CO, higher mPAP–CO slope
3.3× higher 5-yr composite HFH or death.
🔗 https://bit.ly/4hZ3YWl
In 206 pts undergoing invasive exercise testing 🚴♀️, moderate–severe TR (vs absent-mild) was linked to ...
⬇️ cardiac reserve — lower peak CO, higher mPAP–CO slope
3.3× higher 5-yr composite HFH or death.
🔗 https://bit.ly/4hZ3YWl
🚨 High-output heart failure (HOHF): when more isn’t better!
🤔 Which hemodynamic parameter best predicts outcomes in HOHF?
📉 PCWP, PAPi & PAP → not independently linked to mortality
💡 Elevated cardiac index (CI) = strongest predictor of all-cause mortality.
🔗 bit.ly/47EZC3b
🤔 Which hemodynamic parameter best predicts outcomes in HOHF?
📉 PCWP, PAPi & PAP → not independently linked to mortality
💡 Elevated cardiac index (CI) = strongest predictor of all-cause mortality.
🔗 bit.ly/47EZC3b
December 17, 2025 at 8:07 PM
🚨 High-output heart failure (HOHF): when more isn’t better!
🤔 Which hemodynamic parameter best predicts outcomes in HOHF?
📉 PCWP, PAPi & PAP → not independently linked to mortality
💡 Elevated cardiac index (CI) = strongest predictor of all-cause mortality.
🔗 bit.ly/47EZC3b
🤔 Which hemodynamic parameter best predicts outcomes in HOHF?
📉 PCWP, PAPi & PAP → not independently linked to mortality
💡 Elevated cardiac index (CI) = strongest predictor of all-cause mortality.
🔗 bit.ly/47EZC3b
🔎 Can provocative testing during RHC unmask HFpEF?
PAWP with🦵passive leg raise & 🚴♀️low-workload exercise help narrow the diagnostic gray zone.
🧠 Great for ruling in HFpEF — less reliable for ruling it out!
#Hemodynamics #HFpEF
🔗 https://bit.ly/4oxDZro
PAWP with🦵passive leg raise & 🚴♀️low-workload exercise help narrow the diagnostic gray zone.
🧠 Great for ruling in HFpEF — less reliable for ruling it out!
#Hemodynamics #HFpEF
🔗 https://bit.ly/4oxDZro
December 16, 2025 at 3:23 PM
🔎 Can provocative testing during RHC unmask HFpEF?
PAWP with🦵passive leg raise & 🚴♀️low-workload exercise help narrow the diagnostic gray zone.
🧠 Great for ruling in HFpEF — less reliable for ruling it out!
#Hemodynamics #HFpEF
🔗 https://bit.ly/4oxDZro
PAWP with🦵passive leg raise & 🚴♀️low-workload exercise help narrow the diagnostic gray zone.
🧠 Great for ruling in HFpEF — less reliable for ruling it out!
#Hemodynamics #HFpEF
🔗 https://bit.ly/4oxDZro
💭 Should invasive pressure-volume loops be incorporated into diagnostic testing for HFpEF?
‼️Half of pts w/HFpEF can be missed w/RHC even w/exercise! And diagnostic scores for HFpEF have limited sensitivity.
But invasive LV pressure-volume loops can help!
🔗 https://bit.ly/47BRuAu
‼️Half of pts w/HFpEF can be missed w/RHC even w/exercise! And diagnostic scores for HFpEF have limited sensitivity.
But invasive LV pressure-volume loops can help!
🔗 https://bit.ly/47BRuAu
December 11, 2025 at 3:32 PM
💭 Should invasive pressure-volume loops be incorporated into diagnostic testing for HFpEF?
‼️Half of pts w/HFpEF can be missed w/RHC even w/exercise! And diagnostic scores for HFpEF have limited sensitivity.
But invasive LV pressure-volume loops can help!
🔗 https://bit.ly/47BRuAu
‼️Half of pts w/HFpEF can be missed w/RHC even w/exercise! And diagnostic scores for HFpEF have limited sensitivity.
But invasive LV pressure-volume loops can help!
🔗 https://bit.ly/47BRuAu
Your next look at the latest heart failure research is here. 🫀
The latest issue of the Journal of Cardiac Failure is now live and ready to be explored.
View the full issue ➜ https://onlinejcf.com/current
#HeartFailure #JCF #AcademicMedicine
The latest issue of the Journal of Cardiac Failure is now live and ready to be explored.
View the full issue ➜ https://onlinejcf.com/current
#HeartFailure #JCF #AcademicMedicine
December 10, 2025 at 7:57 PM
Your next look at the latest heart failure research is here. 🫀
The latest issue of the Journal of Cardiac Failure is now live and ready to be explored.
View the full issue ➜ https://onlinejcf.com/current
#HeartFailure #JCF #AcademicMedicine
The latest issue of the Journal of Cardiac Failure is now live and ready to be explored.
View the full issue ➜ https://onlinejcf.com/current
#HeartFailure #JCF #AcademicMedicine
🚨Can Assisted Aortic Pulsatility Index (API) help guide weaning from IABP?
📊 Assisted API = (Assisted SBP – Assisted DBP) / PCWP
💡 Original research in JCF's Hemodynamics Focus Issue shows assisted API is a sensitive & specific predictor of successful device weaning.
🔗 https://bit.ly/4oZUa0l
📊 Assisted API = (Assisted SBP – Assisted DBP) / PCWP
💡 Original research in JCF's Hemodynamics Focus Issue shows assisted API is a sensitive & specific predictor of successful device weaning.
🔗 https://bit.ly/4oZUa0l
December 10, 2025 at 4:47 PM
🚨Can Assisted Aortic Pulsatility Index (API) help guide weaning from IABP?
📊 Assisted API = (Assisted SBP – Assisted DBP) / PCWP
💡 Original research in JCF's Hemodynamics Focus Issue shows assisted API is a sensitive & specific predictor of successful device weaning.
🔗 https://bit.ly/4oZUa0l
📊 Assisted API = (Assisted SBP – Assisted DBP) / PCWP
💡 Original research in JCF's Hemodynamics Focus Issue shows assisted API is a sensitive & specific predictor of successful device weaning.
🔗 https://bit.ly/4oZUa0l
Pacemakers in HFpEF = more than a marker⚡
HFpEF+PM pts had ...
Worse biatrial/ventricular function
⬇️exercise reserve
⬆️HFH/death (HR ~ 1.8 vs no PM)
Mechanistic insights demonstrating that pacing may compound mechanical & chronotropic limitations.
🔗 https://bit.ly/4peKkYR
HFpEF+PM pts had ...
Worse biatrial/ventricular function
⬇️exercise reserve
⬆️HFH/death (HR ~ 1.8 vs no PM)
Mechanistic insights demonstrating that pacing may compound mechanical & chronotropic limitations.
🔗 https://bit.ly/4peKkYR
December 9, 2025 at 3:02 PM
Pacemakers in HFpEF = more than a marker⚡
HFpEF+PM pts had ...
Worse biatrial/ventricular function
⬇️exercise reserve
⬆️HFH/death (HR ~ 1.8 vs no PM)
Mechanistic insights demonstrating that pacing may compound mechanical & chronotropic limitations.
🔗 https://bit.ly/4peKkYR
HFpEF+PM pts had ...
Worse biatrial/ventricular function
⬇️exercise reserve
⬆️HFH/death (HR ~ 1.8 vs no PM)
Mechanistic insights demonstrating that pacing may compound mechanical & chronotropic limitations.
🔗 https://bit.ly/4peKkYR
Final Call for Submissions! 🚨
Focus Issue: Infiltrative & Inflammatory Cardiomyopathies
Your research belongs here. Submit to #JCF’s upcoming Focus Issue.
Learn More: bit.ly/46gZVRq
📆Deadline: Dec. 8, 2025
#CardioTwitter #CardiologyResearch #CallForPapers #Hemodynamics #AcademicMedicine
Focus Issue: Infiltrative & Inflammatory Cardiomyopathies
Your research belongs here. Submit to #JCF’s upcoming Focus Issue.
Learn More: bit.ly/46gZVRq
📆Deadline: Dec. 8, 2025
#CardioTwitter #CardiologyResearch #CallForPapers #Hemodynamics #AcademicMedicine
December 8, 2025 at 4:42 PM
Final Call for Submissions! 🚨
Focus Issue: Infiltrative & Inflammatory Cardiomyopathies
Your research belongs here. Submit to #JCF’s upcoming Focus Issue.
Learn More: bit.ly/46gZVRq
📆Deadline: Dec. 8, 2025
#CardioTwitter #CardiologyResearch #CallForPapers #Hemodynamics #AcademicMedicine
Focus Issue: Infiltrative & Inflammatory Cardiomyopathies
Your research belongs here. Submit to #JCF’s upcoming Focus Issue.
Learn More: bit.ly/46gZVRq
📆Deadline: Dec. 8, 2025
#CardioTwitter #CardiologyResearch #CallForPapers #Hemodynamics #AcademicMedicine
New science 🚨!
Simple 1-point mPAP/CO ratios during 🚴♂️CPET w/echo predict outcomes in unexplained dyspnea—matching complex slope methods but with 🔥 higher reproducibility!
Practical tool for assessing #ExercisePH 🫁🫀
#Hemodynmaics #ExerciseTesting #CPET
🔗 https://bit.ly/4patiuW
Simple 1-point mPAP/CO ratios during 🚴♂️CPET w/echo predict outcomes in unexplained dyspnea—matching complex slope methods but with 🔥 higher reproducibility!
Practical tool for assessing #ExercisePH 🫁🫀
#Hemodynmaics #ExerciseTesting #CPET
🔗 https://bit.ly/4patiuW
December 8, 2025 at 3:47 PM
New science 🚨!
Simple 1-point mPAP/CO ratios during 🚴♂️CPET w/echo predict outcomes in unexplained dyspnea—matching complex slope methods but with 🔥 higher reproducibility!
Practical tool for assessing #ExercisePH 🫁🫀
#Hemodynmaics #ExerciseTesting #CPET
🔗 https://bit.ly/4patiuW
Simple 1-point mPAP/CO ratios during 🚴♂️CPET w/echo predict outcomes in unexplained dyspnea—matching complex slope methods but with 🔥 higher reproducibility!
Practical tool for assessing #ExercisePH 🫁🫀
#Hemodynmaics #ExerciseTesting #CPET
🔗 https://bit.ly/4patiuW
Submit Now - Deadline is Approaching!
Focus Issue: Infiltrative & Inflammatory Cardiomyopathies
Share your insights. Elevate the field. Publish early 2026 with #JCF.
Topics: bit.ly/46gZVRq
📆Deadline: Dec. 8, 2025
#CardioTwitter #HeartFailure #CardiologyResearch #CallForPapers #AcademicMedicine
Focus Issue: Infiltrative & Inflammatory Cardiomyopathies
Share your insights. Elevate the field. Publish early 2026 with #JCF.
Topics: bit.ly/46gZVRq
📆Deadline: Dec. 8, 2025
#CardioTwitter #HeartFailure #CardiologyResearch #CallForPapers #AcademicMedicine
December 5, 2025 at 4:46 PM
Submit Now - Deadline is Approaching!
Focus Issue: Infiltrative & Inflammatory Cardiomyopathies
Share your insights. Elevate the field. Publish early 2026 with #JCF.
Topics: bit.ly/46gZVRq
📆Deadline: Dec. 8, 2025
#CardioTwitter #HeartFailure #CardiologyResearch #CallForPapers #AcademicMedicine
Focus Issue: Infiltrative & Inflammatory Cardiomyopathies
Share your insights. Elevate the field. Publish early 2026 with #JCF.
Topics: bit.ly/46gZVRq
📆Deadline: Dec. 8, 2025
#CardioTwitter #HeartFailure #CardiologyResearch #CallForPapers #AcademicMedicine
Benefits of ICDs & CRT-Ds⚡️ in HM3 LVAD pts is uncertain.
This analysis of the MOMENTUM-3 trial showed that the presence of these devices was not associated with ⬆️survival, quality of life, or functional capacity in HM3 LVAD pts.
🔗 bit.ly/43c3HZW
This analysis of the MOMENTUM-3 trial showed that the presence of these devices was not associated with ⬆️survival, quality of life, or functional capacity in HM3 LVAD pts.
🔗 bit.ly/43c3HZW
December 4, 2025 at 5:08 PM
Benefits of ICDs & CRT-Ds⚡️ in HM3 LVAD pts is uncertain.
This analysis of the MOMENTUM-3 trial showed that the presence of these devices was not associated with ⬆️survival, quality of life, or functional capacity in HM3 LVAD pts.
🔗 bit.ly/43c3HZW
This analysis of the MOMENTUM-3 trial showed that the presence of these devices was not associated with ⬆️survival, quality of life, or functional capacity in HM3 LVAD pts.
🔗 bit.ly/43c3HZW
Deadline Approaching!
Focus Issue: Infiltrative & Inflammatory Cardiomyopathies
Your work can drive discovery. Submit to #JCF’s 2026 Focus Issue.
Explore Topics: bit.ly/46gZVRq
📆Deadline: Dec. 8, 2025
#CardioTwitter #HeartFailure #CardiologyResearch #CallForPapers #AcademicMedicine
Focus Issue: Infiltrative & Inflammatory Cardiomyopathies
Your work can drive discovery. Submit to #JCF’s 2026 Focus Issue.
Explore Topics: bit.ly/46gZVRq
📆Deadline: Dec. 8, 2025
#CardioTwitter #HeartFailure #CardiologyResearch #CallForPapers #AcademicMedicine
December 3, 2025 at 8:54 PM
Deadline Approaching!
Focus Issue: Infiltrative & Inflammatory Cardiomyopathies
Your work can drive discovery. Submit to #JCF’s 2026 Focus Issue.
Explore Topics: bit.ly/46gZVRq
📆Deadline: Dec. 8, 2025
#CardioTwitter #HeartFailure #CardiologyResearch #CallForPapers #AcademicMedicine
Focus Issue: Infiltrative & Inflammatory Cardiomyopathies
Your work can drive discovery. Submit to #JCF’s 2026 Focus Issue.
Explore Topics: bit.ly/46gZVRq
📆Deadline: Dec. 8, 2025
#CardioTwitter #HeartFailure #CardiologyResearch #CallForPapers #AcademicMedicine
Effective communication📢 is key in 🫀 Tx!
This article analyzed outcomes of non-native English-speaking (NNES) recipients vs native English-speaking (NES) recipients, and found that there were no diff in 1y & 5y post-HT outcomes📈 between the 2 groups.
🔗 bit.ly/4qGEzEP
This article analyzed outcomes of non-native English-speaking (NNES) recipients vs native English-speaking (NES) recipients, and found that there were no diff in 1y & 5y post-HT outcomes📈 between the 2 groups.
🔗 bit.ly/4qGEzEP
December 3, 2025 at 3:43 PM
Effective communication📢 is key in 🫀 Tx!
This article analyzed outcomes of non-native English-speaking (NNES) recipients vs native English-speaking (NES) recipients, and found that there were no diff in 1y & 5y post-HT outcomes📈 between the 2 groups.
🔗 bit.ly/4qGEzEP
This article analyzed outcomes of non-native English-speaking (NNES) recipients vs native English-speaking (NES) recipients, and found that there were no diff in 1y & 5y post-HT outcomes📈 between the 2 groups.
🔗 bit.ly/4qGEzEP
🖥️ AI can play a key role in prev, early detection & treatment of HF, driven by advancements like multimodal LLMs. But challenges like data privacy, system integration, clinician trust & fairness/bias need to be addressed.
Learn more in this Review: https://bit.ly/4oQyuUr
Learn more in this Review: https://bit.ly/4oQyuUr
December 2, 2025 at 6:47 PM
🖥️ AI can play a key role in prev, early detection & treatment of HF, driven by advancements like multimodal LLMs. But challenges like data privacy, system integration, clinician trust & fairness/bias need to be addressed.
Learn more in this Review: https://bit.ly/4oQyuUr
Learn more in this Review: https://bit.ly/4oQyuUr
In this VA study, the rates of early 🫀follow-up after HFH were low overall & were only modestly associated w/mortality risk at discharge.
Increasing the visit rate after HFH should be evaluated as a mechanism to improve outcomes after HFH!
🔗 bit.ly/493maeW
🧵
Increasing the visit rate after HFH should be evaluated as a mechanism to improve outcomes after HFH!
🔗 bit.ly/493maeW
🧵
December 2, 2025 at 2:46 PM
In this VA study, the rates of early 🫀follow-up after HFH were low overall & were only modestly associated w/mortality risk at discharge.
Increasing the visit rate after HFH should be evaluated as a mechanism to improve outcomes after HFH!
🔗 bit.ly/493maeW
🧵
Increasing the visit rate after HFH should be evaluated as a mechanism to improve outcomes after HFH!
🔗 bit.ly/493maeW
🧵
Don't miss this new study on LVAD-supported patients & caregivers.
It identified ⚡8 facilitators & 🚧 7 barriers to values discussions with clinicians following implant.
🫶 It promotes elicitation & incorporation of patient and caregiver values into care
🖇️ bit.ly/48w3ILI
It identified ⚡8 facilitators & 🚧 7 barriers to values discussions with clinicians following implant.
🫶 It promotes elicitation & incorporation of patient and caregiver values into care
🖇️ bit.ly/48w3ILI
November 25, 2025 at 8:46 PM
Don't miss this new study on LVAD-supported patients & caregivers.
It identified ⚡8 facilitators & 🚧 7 barriers to values discussions with clinicians following implant.
🫶 It promotes elicitation & incorporation of patient and caregiver values into care
🖇️ bit.ly/48w3ILI
It identified ⚡8 facilitators & 🚧 7 barriers to values discussions with clinicians following implant.
🫶 It promotes elicitation & incorporation of patient and caregiver values into care
🖇️ bit.ly/48w3ILI
🚨 Check out this update to 2023 Japanese Heart Failure Society Scientific Statement on BNP and NT-proBNP to learn how to maximize the use of natriuretic peptides to guide evidence-based treatment & prevention of HF.
🖇️ http://bit.ly/499v4r8
🖇️ http://bit.ly/499v4r8
November 24, 2025 at 4:37 PM
🚨 Check out this update to 2023 Japanese Heart Failure Society Scientific Statement on BNP and NT-proBNP to learn how to maximize the use of natriuretic peptides to guide evidence-based treatment & prevention of HF.
🖇️ http://bit.ly/499v4r8
🖇️ http://bit.ly/499v4r8
How do well pts w/pre-HF understand HF symptoms & illness trajectory?
🚨This study in pts w/ACS found key gaps in pt understanding of HF trajectory & impact on life expectancy. Effective measures are needed to improve knowledge & enhance prevention!
🖇️ http://bit.ly/42DQCIB
🚨This study in pts w/ACS found key gaps in pt understanding of HF trajectory & impact on life expectancy. Effective measures are needed to improve knowledge & enhance prevention!
🖇️ http://bit.ly/42DQCIB
November 21, 2025 at 2:47 PM
How do well pts w/pre-HF understand HF symptoms & illness trajectory?
🚨This study in pts w/ACS found key gaps in pt understanding of HF trajectory & impact on life expectancy. Effective measures are needed to improve knowledge & enhance prevention!
🖇️ http://bit.ly/42DQCIB
🚨This study in pts w/ACS found key gaps in pt understanding of HF trajectory & impact on life expectancy. Effective measures are needed to improve knowledge & enhance prevention!
🖇️ http://bit.ly/42DQCIB
💡HFpEF represents a major clinical challenge, with women up to 2x more likely to be affected.
The 🌟 SOTA covers the unique cardiometabolic and hormonal challenges to be considered in the screening, diagnosis, & management of HFpEF in women.
🖇️ http://bit.ly/3IUulzD
The 🌟 SOTA covers the unique cardiometabolic and hormonal challenges to be considered in the screening, diagnosis, & management of HFpEF in women.
🖇️ http://bit.ly/3IUulzD
November 20, 2025 at 6:22 PM
💡HFpEF represents a major clinical challenge, with women up to 2x more likely to be affected.
The 🌟 SOTA covers the unique cardiometabolic and hormonal challenges to be considered in the screening, diagnosis, & management of HFpEF in women.
🖇️ http://bit.ly/3IUulzD
The 🌟 SOTA covers the unique cardiometabolic and hormonal challenges to be considered in the screening, diagnosis, & management of HFpEF in women.
🖇️ http://bit.ly/3IUulzD
🚨 New Science alert! In this 🔥 article, the authors used the AHA's GWTG HF registry to show that there is significant undertesting & underdiagnosis of ATTR-CM among pts hospitalized for HF, with substantial hospital-level variation across US hospitals.
🔗 http://bit.ly/4hgFGXC
🔗 http://bit.ly/4hgFGXC
November 14, 2025 at 3:17 PM
🚨 New Science alert! In this 🔥 article, the authors used the AHA's GWTG HF registry to show that there is significant undertesting & underdiagnosis of ATTR-CM among pts hospitalized for HF, with substantial hospital-level variation across US hospitals.
🔗 http://bit.ly/4hgFGXC
🔗 http://bit.ly/4hgFGXC